Oral GLP-1 drug shows promise for adults with diabetes and obesity
Orforglipron , an investigative and oral GLP-1 drug, appears to enable adults with obesity and Type 2 diabetes to achieve significantly more weight loss and improvement in blood […]
Orforglipron , an investigative and oral GLP-1 drug, appears to enable adults with obesity and Type 2 diabetes to achieve significantly more weight loss and improvement in blood […]
Women treated with antibiotics within 24 hours of having an obstetric tear during childbirth have achieved a lower risk of larger/clinically relevant wound complications than women who do […]
Researchers report that patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) have achieved a 78% reduced risk of death and a 44% reduced risk of major […]
Researchers report that few people in the USA use salt substitutes to help control high blood pressure despite the fact they are a simple and effective method to […]
Use of the diabetes drug metformin appears to be linked to reduced risk of dementia and death in obese patients, researchers reported on August 6, 2025 in Diabetes, […]
Findings from a randomized controlled trial suggest that vaporized nicotine products (vapes) are more effective than nicotine replacement therapies for smoking cessation in a low socioeconomic status population. […]
Simultaneous treatment with tirzepatide and menopause hormone therapy results in greater weight loss in postmenopausal women who are overweight or obese than tirzepatide monotherapy, researchers reported on July […]
A new analysis of data from a U.S. survey shows that 4 in 5 persons report some loneliness, with levels of loneliness mirroring levels of poor mental health […]
The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP) […]
Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat diabetes, appears to reduce monthly migraine days by more than half, researchers reported on June 20, 2025 at […]
Researchers report that investigative ecnoglutide is a safe and effective treatment for weight management in individuals who are overweight or obese and who do not have diabetes. The […]
The use of the anti-contraction (tocolytic) drug atosiban in cases of threatened premature birth after 30 weeks of pregnancy is not more effective than placebo at reducing poor […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.